International Clinical Trial: TAF monotherapy resulted in (extremely) low viremia with prolonged liver fibrosis in CHB patients, who switched to TMF for salvage treatment: A multicenter, randomized controlled, prospective study

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120403) titled 'TAF monotherapy resulted in (extremely) low viremia with prolonged liver fibrosis in CHB patients, who switched to TMF for salvage treatment: A multicenter, randomized controlled, prospective study' on March 13.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: West China Hospital, Sichuan University

Condition: Chronic hepatitis B

Intervention: TMF sequential treatment group:Adefovir (TMF) sequential therapy

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-05-08

Target Sample Size: TMF sequential treatment group:125;TAF maintenance treatment group:125;...